Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining cisplatin eligibility in patients with muscle-invasive bladder cancer
Authors
Keywords
-
Journal
Nature Reviews Urology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-12
DOI
10.1038/s41585-020-00404-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vefora, GETUG-AFU V06 study: Randomized multicenter phase II/III trial of fractionated cisplatin (CI)/gemcitabine (G) or carboplatin (CA)/g in patients (pts) with advanced urothelial cancer (UC) with impaired renal function (IRF)—Results of a planned interim analysis.
- (2020) Loic Mourey et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer
- (2019) Chelsea K. Osterman et al. ONCOLOGIST
- Estimation of Kidney Function in Oncology
- (2019) Morgan A. Casal et al. Clinical Journal of the American Society of Nephrology
- Molecular Characterization of Neuroendocrine-like Bladder Cancer
- (2019) José Batista da Costa et al. CLINICAL CANCER RESEARCH
- Contrast-Associated Acute Kidney Injury
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Organ preservation in bladder cancer: an opportunity for truly personalized treatment
- (2019) Yee Pei Song et al. Nature Reviews Urology
- Systematic review and meta-analysis of the efficacy of clinically tested protectants of cisplatin nephrotoxicity
- (2019) Alfredo G. Casanova et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies
- (2019) Andrea Necchi et al. EUROPEAN UROLOGY
- Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
- (2019) Thomas Powles et al. NATURE MEDICINE
- Improving Cancer Care for Patients With Chronic Kidney Disease
- (2019) Ben Sprangers et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Kidney Function in Patients With Cancer
- (2018) Verônica Torres da Costa e Silva et al. ADVANCES IN CHRONIC KIDNEY DISEASE
- Feasibility of Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer Patients With Diminished Renal Function
- (2018) Vadim S. Koshkin et al. Clinical Genitourinary Cancer
- Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients
- (2018) Janice M. Loh et al. Clinical Genitourinary Cancer
- Pharmacology behind Common Drug Nephrotoxicities
- (2018) Mark A. Perazella Clinical Journal of the American Society of Nephrology
- Representation of Patients With Chronic Kidney Disease in Trials of Cancer Therapy
- (2018) Abhijat Kitchlu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin
- (2018) Shveta S. Motwani et al. JOURNAL OF CLINICAL ONCOLOGY
- A case–control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity
- (2018) Patwant Dhillon et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
- (2018) Thomas Powles et al. JOURNAL OF CLINICAL ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review
- (2018) Zulfan Zazuli et al. Frontiers in Pharmacology
- Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer
- (2018) Charles C. Peyton et al. JAMA Oncology
- Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
- (2018) Andrea Necchi et al. JOURNAL OF CLINICAL ONCOLOGY
- National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
- (2018) Hong-Yiou Lin et al. Cancer Medicine
- Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer
- (2018) Di (Maria) Jiang et al. Clinical Genitourinary Cancer
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- New Model for Estimating Glomerular Filtration Rate in Patients With Cancer
- (2017) Tobias Janowitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin nephrotoxicity: a review of the literature
- (2017) Sandhya Manohar et al. JOURNAL OF NEPHROLOGY
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
- (2017) Sam S. Chang et al. JOURNAL OF UROLOGY
- First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
- (2017) Arjun V Balar et al. LANCET ONCOLOGY
- A Systematic Review of Strategies to Prevent Cisplatin‐Induced Nephrotoxicity
- (2017) Daniel J. Crona et al. ONCOLOGIST
- Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?
- (2016) Naoya Niwa et al. Clinical Genitourinary Cancer
- Long-Term Renal Outcomes after Cisplatin Treatment
- (2016) S. Latcha et al. Clinical Journal of the American Society of Nephrology
- ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy
- (2016) Floris H. Groenendijk et al. EUROPEAN UROLOGY
- Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
- (2016) Ming Yin et al. ONCOLOGIST
- A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis
- (2015) Jennifer R. Eads et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer
- (2015) Elizabeth R. Plimack et al. EUROPEAN UROLOGY
- Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study
- (2015) Jiachen Zhou et al. UROLOGY
- Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer
- (2015) F. Santos et al. Current Oncology
- Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice
- (2014) C. M. Booth et al. ANNALS OF ONCOLOGY
- Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: A review of SEER data, 2004-2010
- (2014) Mary E. Charlton et al. CANCER
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?
- (2014) Youssef Bennis et al. International Journal of Clinical Pharmacy
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients
- (2013) R. Houston Thompson et al. BJU INTERNATIONAL
- Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating prevalence of renal function and predicting survival in the oldest old
- (2013) Jorien M Willems et al. BMC Geriatrics
- Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function
- (2012) Rafael Morales-Barrera et al. EUROPEAN JOURNAL OF CANCER
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment
- (2012) Tomoko Ogawa et al. International Journal of Clinical Oncology
- Notice
- (2012) Kidney International Supplements
- Notice
- (2012) Kidney International Supplements
- Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma
- (2011) M. D. Galsky et al. ANNALS OF ONCOLOGY
- Impact of the CKD-EPI Equation for Estimating Renal Function on Eligibility for Cisplatin-based Chemotherapy in Patients With Urothelial Cancer
- (2011) Che-Kai Tsao et al. Clinical Genitourinary Cancer
- Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy
- (2011) Matthew D. Galsky et al. JOURNAL OF CLINICAL ONCOLOGY
- International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial
- (2011) JOURNAL OF CLINICAL ONCOLOGY
- A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy
- (2011) Matthew D Galsky et al. LANCET ONCOLOGY
- Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients
- (2010) N. Janus et al. ANNALS OF ONCOLOGY
- Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy
- (2010) Daniel Canter et al. BJU INTERNATIONAL
- Occupation and cancer in Britain
- (2010) L Rushton et al. BRITISH JOURNAL OF CANCER
- Percutaneous Urinary Drainage and Ureteric Stenting in Malignant Disease
- (2010) D.J. Allen et al. CLINICAL ONCOLOGY
- Use of Radical Cystectomy for Patients With Invasive Bladder Cancer
- (2010) J. L. Gore et al. JNCI-Journal of the National Cancer Institute
- Treatment of Muscle Invasive Bladder Cancer: Evidence From the National Cancer Database, 2003 to 2007
- (2010) Ugo Fedeli et al. JOURNAL OF UROLOGY
- A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)
- (2009) Ralph W. deVere White et al. JOURNAL OF UROLOGY
- Sex and racial differences in bladder cancer presentation and mortality in the US
- (2008) Emil Scosyrev et al. CANCER
- A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder
- (2008) Atreya Dash et al. CANCER
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
- (2008) N. Pabla et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now